MARY MULLINS: Open Payments
NPI 1073641049 · CENTENNIAL, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$691 in 34 payments from 11 companies in 2025. Trend: 2023 $574 · 2024 $711 · 2025 $691
Food & beverage: $691
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $330 |
| AstraZeneca Pharmaceuticals LP | 3 | $141 |
| Vertex Pharmaceuticals Incorporated | 2 | $38 |
| PFIZER INC. | 2 | $33 |
| Amgen Inc. | 2 | $31 |
| Exact Sciences Corporation | 2 | $30 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Seqirus USA Inc | 1 | $18 |
| Astellas Pharma US Inc | 1 | $14 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: QULIPTA, UBRELVY, FARXIGA, JOURNAVX, NURTEC ODT, Cologuard Collection Kit, SHINGRIX, Fluad.
Industry payments across CO — which companies pay providers there.
